THE FIRST LOT OF PFIZER VACCINE DELIVERED TO KAZAKHSTAN
Today, November 10, 2021, on behalf of the Head of State, the first batch of Pfizer vaccine against COVID-19, approved by the WHO, was delivered to Kazakhstan.
Under the agreement signed earlier, 4 million doses of Comirnaty Pfizer / BioNTech vaccine were purchased. Comirnaty is the trade name for an RNA (mRNA) matrix vaccine produced by the American company Pfizer and the German technology company BioNTech. The vaccination course consists of two doses, which are administered at intervals of 21-28 days. The delivered doses will allow progress in completing the mass vaccination of the population of the Republic of Kazakhstan.
This is the sixth vaccine registered in Kazakhstan. A single distributor of the arrived vaccine will be sent to the regions of the country in an expeditious manner according to the order of the KSEC MZRK. And in the coming days it will be available for vaccination against coronavirus infection of citizens of the Republic of Kazakhstan. In order to strictly follow the instructions for storing the vaccine and prevent negative consequences, measures were taken to prepare for the delivery and use of the vaccine. In accordance with the manufacturer’s recommended cold chain requirements, freezing equipment was purchased for storage at an ultra-low temperature of -60 -90 Сo. Also, the necessary supply of syringes was purchased for the administration of the vaccine. Appropriate vaccination personnel have been trained in the correct handling and administration of the vaccine.
The Comirnaty Pfizer / BioNTech vaccine is approved for emergency use by WHO and is used in the US, UK, Canada and the EU. According to the results of clinical studies, its effectiveness is 95 percent. This is the very first vaccine to be used in the United States under the so-called Emergency Use Authorization (EUA).
It should be reminded that the following vaccines were used in Kazakhstan for the vaccination of the population: QazVac, Sputnik V, Hayat-Vax, CoronaVac, Sinopharm.